Literature DB >> 24603957

Removing the hype from hypertension.

Matthew J Shun-Shin1, James P Howard, Darrel P Francis.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24603957     DOI： 10.1136/bmj.g1937

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

Review 1.  The sympathetic nervous system in hypertension: back to the future?

Authors:  Murray Esler
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 2.  Renal Denervation After Symplicity HTN-3 - Back to Basics. Review of the Evidence.

Authors:  Alexandre Persu; Fadl Elmula M Fadl Elmula; Yu Jin; Ingrid Os; Sverre E Kjeldsen; Jan A Staessen
Journal:  Eur Cardiol       Date:  2014-12

Review 3.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 4.  Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.

Authors:  Alexandre Persu; Sverre Kjeldsen; Jan A Staessen; Michel Azizi
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

Review 5.  Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension.

Authors:  Fadl Elmula M Fadl Elmula; Anne C Larstorp; Sverre E Kjeldsen; Alexandre Persu; Yu Jin; Jan A Staessen
Journal:  Front Physiol       Date:  2015-02-09       Impact factor: 4.566

6.  Assessment of Accuracy of Waterfall Plot Representations of Response Rates in Cancer Treatment Published in Medical Journals.

Authors:  Myung Sun Kim; Vinay Prasad
Journal:  JAMA Netw Open       Date:  2019-05-03

Review 7.  Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement.

Authors:  Michael R Rosen; Robert J Myerburg; Darrel P Francis; Graham D Cole; Eduardo Marbán
Journal:  J Am Coll Cardiol       Date:  2014-09-02       Impact factor: 24.094

8.  Frequency of discrepancies in retracted clinical trial reports versus unretracted reports: blinded case-control study.

Authors:  Graham D Cole; Alexandra N Nowbar; Michael Mielewczik; Matthew J Shun-Shin; Darrel P Francis
Journal:  BMJ       Date:  2015-09-20

Review 9.  Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients.

Authors:  Daniel Keene; Clare Price; Matthew J Shun-Shin; Darrel P Francis
Journal:  BMJ       Date:  2014-07-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.